Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 294 (RNA5SP294) is a human gene annotated as a pseudogene of ribosomal 5S RNA[2][4]. Pseudogenes, such as RNA5SP294, are genomic DNA sequences similar to known genes but are typically nonfunctional; they lack the ability to produce functional proteins or functional non-coding RNAs due to mutations, truncations, or lack of regulatory elements[4]. 5S rRNA itself is a critical component of the large ribosomal subunit, participating in ribosome structure and function, but pseudogenes like RNA5SP294 are considered genetic relics without direct functional or therapeutic significance[1][5]. Recent research suggests that the expression of pseudogenes in general can have value as biomarkers and may play indirect regulatory roles in diseases such as cancer, though RNA5SP294 specifically is not reported as a therapeutic target, disease gene, or biomarker under current knowledge[6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 294 (RNA5SP294).